Proteomics International, Australia
PromarkerD - Leading the world in predictive diabetic kidney disease with up to 4 years prognosis
Over time, high blood glucose and high blood pressure associated with diabetes can damage the blood vessels in the kidneys. Kidney damage caused by diabetes can lead to kidney failure and the need for dialysis or even kidney transplantation. Worryingly,
most people with developing diabetic kidney disease show no symptoms and are oftentimes diagnosed at an advanced stage.
PromarkerD is a new generation of predictive medtech to help the healthcare of 30 million people (in the USA alone) with type2 diabetes. PromarkerD assists in saving lives and improving patient livelihood through a simple blood test that can detect the risk of getting DKD with up to 4years advance notice.
PromarkerD can be run regularly to monitor patient risk, thereby assessing patient DKD health, and allowing the patient to make interventions that can delay or avoid the cost of DKD related dialysis and surgery. The test helps patients make good lifestyle changes to stay healthy and happy, and give them the best chance to avoid diabetic kidney disease altogether.